LIN SUE-JEAN (CIK 1867788) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-26). Recent activity: Buy STVN (4,975 shares), Sell ARQT (4,946 shares), Buy ARQT (5,778 shares), Buy ARQT (18,052 shares), Buy ARQT (7,220 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Stevanato Group S.p.A. (STVN) | Director | Buy | 4,975 | $0 |
| 2026-06-17 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 4,946 | $120,587 |
| 2026-06-09 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 5,778 | $0 |
| 2025-11-25 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 18,052 | $155,789 |
| 2025-11-25 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 7,220 | $54,222 |
| 2025-11-25 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 25,272 | $777,872 |
| 2025-06-16 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 7,609 | $0 |
Source: SEC Form 4 filings · as of 2026-06-26